您当前的位置：
首页 >
文章列表页 >
Exploring Mechanism of Modified Banxia Xiexintang in Ameliorating Metabolic Disorders and Reproductive Function in PCOS-IR Rats Based on Metabolomics and Transcriptomics
更新时间：2026-03-03

    • Exploring Mechanism of Modified Banxia Xiexintang in Ameliorating Metabolic Disorders and Reproductive Function in PCOS-IR Rats Based on Metabolomics and Transcriptomics

      增强出版
    • “Experts evaluated the therapeutic effect of Jiawei Banxia Xiexin Tang on polycystic ovary syndrome with insulin resistance rats based on the combined analysis technology of transcriptomics and metabolomics, revealing its potential mechanism and providing new ideas for the treatment of related diseases.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 7, Pages: 140-149(2026)

    • DOI：10.13422/j.cnki.syfjx.20260164    

      CLC： R242;R271.1;R856.2

    • Received：25 November 2025，

      Revised：2026-01-23，

      Accepted：06 February 2026，

      Online First：09 February 2026，

      Published：05 April 2026

    移动端阅览

  • BAI Donghan,TANG Ruying,LIN Longfei,et al.Exploring Mechanism of Modified Banxia Xiexintang in Ameliorating Metabolic Disorders and Reproductive Function in PCOS-IR Rats Based on Metabolomics and Transcriptomics[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(07):140-149. DOI： 10.13422/j.cnki.syfjx.20260164.

  •  
  •  

0

Views

9

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Investigation on Mechanism of Modified Banxia Xiexintang in Improving Ovarian Dysfunction of PCOS-IR Rats by Inhibiting Ferroptosis via AMPK/FASN/GPX4 Signaling Pathway
Integrative Strategies of Traditional Chinese and Western Medicine for Polycystic Ovary Syndrome with Insulin Resistance： Synergistic Potentiation Mechanisms Based on Pathogenic Complementarity
Comparison of Wild and Cultivated Bupleurum scorzonerifolium Based on Traditional Quality Evaluation

Related Author

LI Hui
TANG Ruying
LIU Hengchang
LIN Longfei
LIU Yuling
YUAN Changsheng
ZHOU Feng
LIU Xingyu

Related Institution

Institute of Traditional Chinese Medicine Health Industry， China Academy of Chinese Medical Sciences
Graduate School of PLA General Hospital
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs， National Resource Center for Chinese Materia Medica， China Academy of Chinese Medical Sciences
College of Chemistry and Chemical Engineering，Xianyang Normal University
Shaanxi Health Guardian Liuwei Pharmaceutical Co. Ltd.
0